For every 500 people reading this, one likely has a disease called hypertrophic cardiomyopathy (HCM). It is the most common genetic heart condition in the world, primarily caused by mutations that thicken heart muscle and, in rare cases, lead to heart failure and cardiac arrest.
Today, the Allen Institute for Cell Science launched a set of tools to accelerate research into this global health issue: six new cell line collections, each carrying a different mutation associated with HCM. These cells will help scientists worldwide investigate the impact of specific mutations in myosin, a protein that powers heart contractions, on heart function.
